Yingru, L., & Shaotang, L. (2022). [Comment] Compara tive effectiveness of bevacizumab versus cetuximab in meta static colorectal cancer patients without primary tumor resec tion. Editorial Office of Journal of Colorectal & Anal Surgery.
Chicago Style (17th ed.) CitationYingru, Li, and Li Shaotang. [Comment] Compara Tive Effectiveness of Bevacizumab Versus Cetuximab in Meta Static Colorectal Cancer Patients Without Primary Tumor Resec Tion. Editorial Office of Journal of Colorectal & Anal Surgery, 2022.
MLA (9th ed.) CitationYingru, Li, and Li Shaotang. [Comment] Compara Tive Effectiveness of Bevacizumab Versus Cetuximab in Meta Static Colorectal Cancer Patients Without Primary Tumor Resec Tion. Editorial Office of Journal of Colorectal & Anal Surgery, 2022.
Warning: These citations may not always be 100% accurate.